In silico evaluation of the effectivity of approved protease inhibitors against the main protease of the novel SARS-CoV-2 virus
P Eleftheriou, D Amanatidou, A Petrou, A Geronikaki - Molecules, 2020 - mdpi.com
The coronavirus disease, COVID-19, caused by the novel coronavirus SARS-CoV-2, which
first emerged in Wuhan, China and was made known to the World in December 2019 turned …
first emerged in Wuhan, China and was made known to the World in December 2019 turned …
In silico identification of clinically approved medicines against the main protease of SARS-CoV-2, causative agent of covid-19
The COVID-19 pandemic triggered by SARS-CoV-2 is a worldwide health disaster. Main
protease is an attractive drug target among coronaviruses, due to its vital role in processing …
protease is an attractive drug target among coronaviruses, due to its vital role in processing …
Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2
K Kodchakorn, Y Poovorawan, K Suwannakarn… - Journal of Molecular …, 2020 - Elsevier
The widespread problem of a 2019-novel coronavirus (SARS-CoV-2) strain outbreak in
Wuhan, China has prompted a search for new drugs to protect against and treat this …
Wuhan, China has prompted a search for new drugs to protect against and treat this …
Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
A Mukherjee, KM Pandey, KK Ojha… - Beni-Suef University …, 2023 - Springer
Background COVID-19 was declared a pandemic by the World Health Organisation in 2020
after its outbreak in December 2019 in Wuhan, China. Since researchers have been working …
after its outbreak in December 2019 in Wuhan, China. Since researchers have been working …
Inhibition of SARS-CoV-2 main protease 3CLpro by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking
AO Elzupir - Journal of Molecular Structure, 2020 - Elsevier
The coronavirus disease infections (COVID-19) caused by a new type of coronavirus (SARS-
CoV-2) have been emerging in the entire world. Therefore, it is necessary to find out …
CoV-2) have been emerging in the entire world. Therefore, it is necessary to find out …
In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme
S Chatterjee, A Maity, S Chowdhury… - Journal of …, 2021 - Taylor & Francis
The recent outbreak of the 2019 novel coronavirus disease (COVID-19) has been proved as
a global threat. No particular drug or vaccine has not yet been discovered which may act …
a global threat. No particular drug or vaccine has not yet been discovered which may act …
[HTML][HTML] In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease
The pandemic that started in Wuhan (China) in 2019 has caused a large number of deaths,
and infected people around the world due to the absence of effective therapy against …
and infected people around the world due to the absence of effective therapy against …
In silico prediction of novel inhibitors of SARS-CoV-2 main protease through structure-based virtual screening and molecular dynamic simulation
The unprecedented pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is threatening global health. SARS-CoV-2 has caused severe disease with …
CoV-2) is threatening global health. SARS-CoV-2 has caused severe disease with …
In silico evaluation of prospective anti-COVID-19 drug candidates as potential SARS-CoV-2 main protease inhibitors
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emanating
human infectious coronavirus that causes COVID-19 disease. On 11th March 2020, it has …
human infectious coronavirus that causes COVID-19 disease. On 11th March 2020, it has …
[HTML][HTML] In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
Developing a safe and effective antiviral treatment takes a decade, however, when it comes
to the coronavirus disease (COVID-19), time is a sensitive matter to slow the spread of the …
to the coronavirus disease (COVID-19), time is a sensitive matter to slow the spread of the …
相关搜索
- sars cov main protease
- silico evaluation protease inhibitors
- sars cov silico evaluation
- silico prediction main protease
- potent inhibitors main protease
- sars cov potent inhibitors
- sars cov docking analysis
- covid 19 main protease
- docking analysis main protease
- sars cov covid 19
- α ketoamide main protease
- silico evaluation drug candidates
- protease enzyme silico analysis
- drug candidates protease inhibitors
- sars cov drugs and nutraceuticals
- sars cov α ketoamide